PDB17 TOTAL Cost of Care and Utilization Among Medicare Fee-for-Service (FFS) Patients with Metastatic Pancreatic Cancer Treated with FDA-Approved/NCCN® Category 1 Regimens at 340B VS. NON-340B Hospitals
Jun 1, 2021, 00:00 AM
10.1016/j.jval.2021.04.415
https://www.valueinhealthjournal.com/article/S1098-3015(21)00632-X/fulltext
Section Title :
Section Order :
10983
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)00632-X&doi=10.1016/j.jval.2021.04.415